Bioequivalence Study for an Isotretinoin

NCT01863615 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Infections (Acne)

Interventions

DRUG: Isotretinoin 40 mg
DRUG: Isotretinoin 40 mg

Sponsor

GlaxoSmithKline